Cingulate CINGW
NASDAQ CINGW
$0.01 +0.00 (+4.29%)
As of: Sep 9, 2026 · 11:16 AM EDT

Cingulate (CINGW) Current Assets (2021 - 2026)

Cingulate's (CINGW) quarterly Current Assets came in at $30.2 million in Q2 2026, up 151.56% quarter-over-quarter from $12.0 million in Q4 2025.

Analysis

Cingulate (CINGW) Current Assets (2021 - 2026) Analysis & Trends

Cingulate (CINGW) has reported Current Assets for 6 consecutive years, with $30.2 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Current Assets changed N/A year-over-year to $30.2 million; the trailing twelve-month figure through Jun 2026 stood at $30.2 million (changed N/A YoY), and the FY2025 full-year result was $12.0 million, down 5.15% from the prior year.
  • Current Assets rose to $30.2 million in Q2 2026 per CINGW's latest filing, from $12.0 million in the prior quarter.
  • Across five years, Current Assets topped out at $30.2 million in Q2 2026 and bottomed at $578594.0 in Q4 2023.
  • Historically, Current Assets has averaged $8.9 million across 5 years, with a median of $9.0 million in 2022.
  • The sharpest annual moves came in 2023 and 2024: Current Assets sank 92.65% in 2023, then soared 2088.2% in 2024.
  • Over 5 years, Current Assets stood at $7.9 million in 2022, then tumbled by 92.65% to $578594.0 in 2023, then jumped by 2088.2% to $12.7 million in 2024, then decreased by 5.15% to $12.0 million in 2025, then soared by 151.56% to $30.2 million in 2026.
  • According to Business Quant data, Current Assets over the past three periods registered $30.2 million, $12.0 million, and $7.4 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Johnson & Johnson 644.46 Bn 623.70 Bn 17.26 Bn 59.77 Bn
2 AbbVie 440.11 Bn 433.54 Bn 12.70 Bn 33.67 Bn
3 Merck 365.04 Bn 357.90 Bn 12.21 Bn 36.68 Bn
4 Novartis Ag 266.82 Bn 259.13 Bn 11.24 Bn 27.35 Bn
5 Pfizer 159.14 Bn 147.45 Bn 10.94 Bn 41.36 Bn
6 Sanofi 52.47 Bn 45.09 Bn 10.79 Bn 36.64 Bn
7 Revolution Medicines 44.26 Bn 44.26 Bn - 4.03 Bn
8 Incyte 25.32 Bn 20.79 Bn 1.57 Bn 6.03 Bn
9 United Therapeutics 21.46 Bn 18.80 Bn 683.80 Mn 3.48 Bn
10 Cingulate 100,214.03 100,214.03 - 30.21 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 30.21 Mn
Dec 31, 2025 12.01 Mn
Sep 30, 2025 7.43 Mn
Mar 31, 2025 10.50 Mn
Dec 31, 2024 12.66 Mn
Sep 30, 2024 11.34 Mn
Jun 30, 2024 2.52 Mn
Mar 31, 2024 2.73 Mn
Dec 31, 2023 578,594.00
Sep 30, 2023 2.90 Mn
Jun 30, 2023 2.04 Mn
Mar 31, 2023 3.75 Mn
Dec 31, 2022 7.87 Mn
Sep 30, 2022 11.83 Mn
Jun 30, 2022 10.10 Mn
Mar 31, 2022 14.57 Mn
Dec 31, 2021 18.88 Mn